44 Fanconi Anemia Clinical Trials in Chicago, IL (2026)

Q: How do I join a clinical trial in Chicago?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you.

Recruiting Fanconi Anemia Studies in Chicago

NCT00063063Recruiting

Generic Database of Very Low Birth Weight Infants

The Generic Database (GDB) is a registry of very low birth weight infants born alive in NICHD Neonatal Research Network (NRN) centers. The GDB collects observational baseline data on both mothers and ...

Chicago, IL80,000 participantsNICHD Neonatal Research Network

View Study Details

NCT00009633Recruiting

Follow-up Visit of High Risk Infants

The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, n...

Chicago, IL68,000 participantsNICHD Neonatal Research Network

View Study Details

NCT04573660Recruiting

Abbott Vascular Medical Device Registry

The AV-MDR is a prospective, non-randomized, open-label, multi-center registry. The purpose of the AV-MDR study is to proactively collect and evaluate clinical data on the usage of the devices in scop...

Chicago, IL3,784 participantsAbbott Medical Devices

View Study Details

NCT07136610Recruiting

Standardized Application of Feeding Evaluations Using SMART Tool

Premature and medically complex infants have delayed development of oral feeding skills, leading to prolonged hospitalization, costs, and family stress. There is no "gold standard" infant feeding skil...

Chicago, ILNA3,500 participantsWake Forest University Health Sciences

View Study Details

NCT06526988Recruiting

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

An increasing number of guideline-directed medical therapies (GDMT) have been developed for patients with chronic heart failure with reduced ejection fraction (HFrEF). When used in combination at reco...

Chicago, ILNA2,200 participantsUniversity of Colorado, Denver

View Study Details

NCT06934876Recruiting

Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults

This study will compare the sensitivity and specificity of waveform capnography versus colorimetric carbon dioxide detection to identify tracheal placement of the endotracheal tube during intubation o...

Chicago, IL2,092 participantsBrian Driver

View Study Details

NCT02901184Recruiting

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFPEF) is common and deadly but without therapy. Inconclusive studies such as TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldo...

Chicago, ILPHASE32,000 participantsUppsala University

View Study Details

NCT07232069Recruiting

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. This clinical trial will test if screening and early treatment of mild hea...

Chicago, ILPHASE31,500 participantsDuke University

View Study Details

NCT07145138Recruiting

UIC Multi-Ethnic DCM Registry

Dilated cardiomyopathy (DCM), a condition where the heart loses its ability to pump blood throughout the body, is a common cause of death in the United States (US). It affects minorities more frequent...

Chicago, IL1,500 participantsUniversity of Illinois at Chicago

View Study Details

NCT06438315Recruiting

SuperSaturated Oxygen Comprehensive Observational Registry

The SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility, infarct size reduction, and cost-...

Chicago, IL1,000 participantsTherOx

View Study Details

NCT05873634Recruiting

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands of the body, resulting in shortness of br...

Chicago, IL1,000 participantsNorthwestern University

View Study Details

NCT04334707Recruiting

Kidney Precision Medicine Project

Acute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden. Yet, no effective therapies currently exist for AKI, and only a few are available for CKD. Despit...

Chicago, IL1,000 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06876649Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....

Chicago, ILPHASE4787 participantsEli Lilly and Company

View Study Details

NCT04629014Recruiting

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using dat...

Chicago, IL750 participantsBoston Children's Hospital

View Study Details

NCT06678841Recruiting

ELEVATE-HFpEF Clinical Study

ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compar...

Chicago, ILNA700 participantsMedtronic Cardiac Rhythm and Heart Failure

View Study Details

NCT06991257Recruiting

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

The purpose of this study is to learn about the safety and effects of the study medicine (PF-07328948) for the possible treatment of heart failure (HF)....

Chicago, ILPHASE2620 participantsPfizer

View Study Details

NCT06205225Recruiting

iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure

The goal of this factorial randomized trial is to examine the independent and synergistic efficacies of two mobile health technology interventions in people with chronic heart failure. The first inter...

Chicago, ILNA360 participantsUniversity of Illinois at Chicago

View Study Details

NCT06278961Recruiting

Families Filming Infants Learning Movement

The study objective is to improve accuracy in the early detection of neurodevelopmental impairment, especially CP, by evaluating the timepoint (in weeks post term age) that the Prechtl GMA is most use...

Chicago, IL350 participantsAnn & Robert H Lurie Children's Hospital of Chicago

View Study Details

NCT07094659Recruiting

Aging and Task-specific Training to Reduce Falls

The goal of this clinical trial is to examine the effects of a novel task-specific balance training for reducing environmental falls in community ambulatory older adults who are at-risk of falling. Th...

Chicago, ILPHASE1315 participantsUniversity of Illinois at Chicago

View Study Details

NCT06517186Recruiting

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a ...

Chicago, IL180 participantsNorthwestern University

View Study Details

NCT06950385Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

The main goal of this clinical trial is to learn if the drug eRapa works to slow down the progression of disease in patients diagnosed with Familial Adenomatous Polyposis (FAP). Researchers will compa...

Chicago, ILPHASE3168 participantsRapamycin Holdings Inc.

View Study Details

NCT06917911Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

This phase II MYELOMATCH treatment trial compares the effect of venetoclax to gemtuzumab ozogamicin, when given with cytarabine and daunorubicin ("7+3" regimen), for the treatment of patients with cor...

Chicago, ILPHASE2162 participantsNational Cancer Institute (NCI)

View Study Details

NCT05711732Recruiting

Busulfan Sample Collection Study

Busulfan (Busulfex®) is an alkylating drug used as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. Busulfan has wide inter- and intra-patient pharmacokinetic variab...

Chicago, IL150 participantsSaladax Biomedical, Inc.

View Study Details

NCT04592445Recruiting

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

The purpose of this clinical study is to evaluate the safety and early effectiveness of a catheter-based procedure that treats a nerve called the right greater splanchnic nerve. The study includes peo...

Chicago, ILNA150 participantsAxon Therapies, Inc.

View Study Details

NCT06532890Recruiting

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

This study aims to discover circulating microRNAs (associated with drug doses and levels) that can be used to characterize the overall immune state in pediatric heart transplant patients and predict p...

Chicago, IL150 participantsInova Health Care Services

View Study Details

NCT06055439Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

The goal of this clinical trial is to evaluate CHM-2101, an autologous CDH17 CAR T-cell therapy for the treatment of advanced gastrointestinal (GI) cancers that are relapsed or refractory to at least ...

Chicago, ILPHASE1135 participantsChimeric Therapeutics

View Study Details

NCT06910943Recruiting

Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support

TARA-001-301 is a Phase 2b/3 randomized Open-Label Dose-Selection study with an Open-Label Extension and randomized Double-Blind, Placebo-Controlled Study with Open-Label Extension to investigate the ...

Chicago, ILPHASE2129 participantsProtara Therapeutics

View Study Details

NCT06049680Recruiting

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Evaluate the risk of developing EFAD and/or PNAC in adult and pediatric patients 1 month of age and older, who are anticipated to need 8 weeks or longer of parenteral nutrition treatment with SMOFlipi...

Chicago, ILPHASE4100 participantsFresenius Kabi

View Study Details

NCT07420114Recruiting

Outpatient Visits Versus Telehealth for Postoperative Care After Minimally Invasive Gynecologic Surgery

Telehealth, or telemedicine, utilizes technology to deliver clinical care remotely, either in real time or asynchronously, between clinician and patient. Telemedicine has been successfully implemented...

Chicago, IL100 participantsUniversity of Chicago

View Study Details

NCT06663358Recruiting

A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

A multi-centre, multi-country, observational, non-interventional, retrospective and prospective (hybrid) study among Fabry disease participants treated with pegunigalsidase alfa (Elfabrio®) in routine...

Chicago, IL100 participantsChiesi Farmaceutici S.p.A.

View Study Details

NCT04699799Recruiting

Characterization of Human Olfactory Amygdala Subregions

We aim to better understand the subregions of the human amygdala that receive direct projections from the olfactory bulb...

Chicago, ILNA100 participantsNorthwestern University

View Study Details

NCT05432479Recruiting

Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief

This study evaluates the efficacy of single strain probiotic administered in a form of a sachet in the treatment of infant colic in infants 3-12 weeks old....

Chicago, ILNA80 participantsThe Archer-Daniels-Midland Company

View Study Details

NCT07335510Recruiting

Impact of Barostimulation on Hemodynamics in Adults With Heart Failure

This study evaluates the effects of the implantation and adjustment of the CVRx Barostim device in adult patients with heart failure with reduced ejection fraction who are receiving maximally tolerate...

Chicago, ILNA58 participantsColumbia University

View Study Details

NCT07088055Recruiting

Trial to Compare the Effects of Myo Munchee Therapy and Oral Motor Therapy (OMT) in Pediatric Patients to Treat Maxillary Deficiency and Orofacial Myofunctional Dysfunction (OMD).

Multi-center, 6-month, randomized, and controlled trial to compare the effects of Myo Munchee therapy and Oral Motor Therapy (OMT) in pediatric patients (aged 3-5 years) to treat maxillary deficiency ...

Chicago, ILNA48 participantsMyo Munchee (Operations) Pty Ltd

View Study Details

NCT06355310Recruiting

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety of SGLT2 inhibitors for treating NAFLD in ...

Chicago, ILPHASE240 participantsJustin Ryder

View Study Details

NCT07074574Recruiting

Characterization of Human Olfactory Amygdala Subregions exp2

We aim to better understand the functions of the subregions of the human amygdala that receive direct projections from the olfactory bulb...

Chicago, ILNA40 participantsNorthwestern University

View Study Details

NCT05919680Recruiting

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NST-6179 in subjects with ...

Chicago, ILPHASE236 participantsNorthSea Therapeutics B.V.

View Study Details

NCT07742189Recruiting

Medication Collaboration Feasibility Study

This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take mult...

Chicago, ILNA30 participantsNorthwestern University

View Study Details

NCT06473532Recruiting

TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure

The goal of this study is to determine whether an individually tailored text messaging intervention can improve self-care in older adult patients with heart failure. The main question it aims to answe...

Chicago, ILNA30 participantsUniversity of Illinois at Chicago

View Study Details

NCT06343831Recruiting

Quantitative Assessment of Autologous Fat Transfer

This is a single-arm, prospective pilot study that will objectively assess outcomes in patients electively undergoing Autologous Fat Transfer (AFT) for breast or chest wall reconstruction. Patients pl...

Chicago, ILNA15 participantsUniversity of Chicago

View Study Details

NCT07060651Recruiting

Characterization of Human Olfactory Amygdala Subregions Exp3

We aim to better understand the functions of the subregions of the human amygdala that receive direct projections from the olfactory bulb...

Chicago, ILNA12 participantsNorthwestern University

View Study Details

NCT06560762Recruiting

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

A Phase 1, Open label, Multiple Ascending Dose Study to Assess Safety and Tolerability of STM-01 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)...

Chicago, ILPHASE112 participantsSecretome Therapeutics

View Study Details

NCT06270316Recruiting

Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease

The main goals of this clinical study are to characterize safety and PK/PD of AMT-191 i.e. if drug doses used in the study are safe and tolerable and to understand how it acts in the body of people wi...

Chicago, ILPHASE112 participantsUniQure Biopharma B.V.

View Study Details

NCT05700617Recruiting

Cardiac Power Output in Cardiogenic Shock Patients

The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients....

Chicago, ILEARLY_PHASE15 participantsUniversity of Chicago

View Study Details

About Fanconi Anemia Clinical Trials in Chicago

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 44 fanconi anemia clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 173,500 participants. Research is being sponsored by NICHD Neonatal Research Network, Abbott Medical Devices, Wake Forest University Health Sciences and 30 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Chicago — FAQ

Are there fanconi anemia clinical trials in Chicago?

Yes, there are 44 fanconi anemia clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 44 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated August 30, 2026 from ClinicalTrials.gov